Sanofi SA SAN-FR:Euronext Paris

RT Quote | Exchange | EUR

Last | 04/30/24 CEST

93.08

+1.24 (+1.35%)

Volume

2,023,229

52 week range

80.60 - 104.32

Open91.97
Day High93.18
Day Low91.92
Prev Close91.84
52 Week High104.32
52 Week High Date10/13/23
52 Week Low80.60
52 Week Low Date10/27/23

Key Stats

Market Cap122,097.07M
Shares Out1,251.35M
10 Day Average Volume1.73M
Dividend3.76
Dividend Yield4.04%
Beta0.51
YTD % Change3.7

KEY STATS

Open91.97
Day High93.18
Day Low91.92
Prev Close91.84
52 Week High104.32
52 Week High Date10/13/23
52 Week Low80.60
52 Week Low Date10/27/23
Market Cap122,097.07M
Shares Out1,251.35M
10 Day Average Volume1.73M
Dividend3.76
Dividend Yield4.04%
Beta0.51
YTD % Change3.7

RATIOS/PROFITABILITY

EPS (TTM)3.62
P/E (TTM)25.68
Fwd P/E (NTM)-
EBITDA (TTM)-
ROE (TTM)-
Revenue (TTM)-
Gross Margin (TTM)-
Net Margin (TTM)-
Debt To Equity (MRQ)-

EVENTS

Earnings Date-
Ex Div Date05/30/2023
Div Amount3.56
Split Date-
Split Factor-

Latest On Sanofi SA

Sanofi CEO Paul Hudson on Q1 results: Hope to gather even more momentum later this yearApril 25, 2024CNBC.com
Drug similar to Ozempic slowed progression of Parkinson's disease in trialApril 4, 2024CNBC.com

Content From Our Affiliates

FTC expands patent listing challenges for drugsApril 30, 2024TipRanks
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Gilead Sciences (GILD) and Sanofi (OtherSNYNF)April 30, 2024TipRanks
Sanofi price target raised to EUR 98 from EUR 94 at JPMorganApril 29, 2024TipRanks
Deutsche Bank Reaffirms Their Sell Rating on Sanofi (SNYNF)April 29, 2024TipRanks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sanofi (OtherSNYNF), NewAmsterdam Pharma Company (NAMS) and Humana (HUM)April 29, 2024TipRanks

Profile

Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The...

Frederic Oudea

Independent Chairman of the Board

Paul Hudson Ph.D.

Chief Executive Officer, Executive Director, Member of the Executive Committee

Francois-Xavier Roger

Chief Financial Officer, Member of the Executive Committee

Roy Papatheodorou

Executive Vice President, General Counsel, Member of the Executive Committee

Brendan O'Callaghan

Executive Vice President - Global Manufacturing and Supply, Member of the Executive Committee

Address

46 Avenue de la Grande Armee

Paris

75017

France

https://www.sanofi.com/